Q-Line Biotech (NSE:QLINE) Other Financing: ₹-147 Mil (TTM As of Mar. 2025)


NSE:QLINE Q-Line Biotech Ltd NSE:QLINE
12 GF Score
Price ₹546.50
! 2 Warning Signs
View Full Analysis

What is Q-Line Biotech Other Financing?

Q-Line Biotech NSE:QLINE -5.15% 12 Other Financing is ₹-147 Mil as of Mar. 2025. GuruFocus rates NSE:QLINE with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Q-Line Biotech's Other Financing for the six months ended in Mar. 2025 was ₹-147 Mil.

Q-Line Biotech's Other Financing for the trailing twelve months (TTM) ended in Mar. 2025 was ₹-147 Mil.

Q-Line Biotech Other Financing Historical Data

* Premium members only.

The historical data trend for Q-Line Biotech's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-Line Biotech Other Financing Chart

Q-Line Biotech Annual Data
Trend Mar23 Mar24 Mar25
Other Financing
-37.96 -62.75 -147.00

Q-Line Biotech Semi-Annual Data
Mar23 Mar24 Mar25
Other Financing -37.96 -62.75 -147.00
NSE:QLINE
12GF Score
Q-Line Biotech Ltd NSE:QLINE
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-Line Biotech Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Financing for the trailing twelve months (TTM) ended in Mar. 2025 was ₹-147 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of ₹-147 Mil mean?
Q-Line Biotech (NSE:QLINE) has a Other Financing of ₹-147 Mil as of Mar. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Q-Line Biotech and its competitors.
Is Q-Line Biotech's Other Financing too high?
Q-Line Biotech's current Other Financing is ₹-147 Mil. Overall, Q-Line Biotech has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Q-Line Biotech's Other Financing compare to ABT and SYK?
Q-Line Biotech's Other Financing of ₹-147 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Devices & Instruments company?
A good Other Financing depends on the Medical Devices & Instruments industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Q-Line Biotech and its competitors. Q-Line Biotech's current Other Financing is ₹-147 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-Line Biotech stock overvalued right now?
Q-Line Biotech (NSE:QLINE) has a current Other Financing of ₹-147 Mil. The current Other Financing is ₹-147 Mil. Q-Line Biotech's overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Q-Line Biotech (NSE:QLINE), the current Other Financing is ₹-147 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q-Line Biotech Business Description

Address Kanpur Road Adjacent Transport Nagar Metro Station, 298-281, Transport Nagar, Lucknow, UP, IND, 226012
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
12GF Score

Get the complete analysis for NSE:QLINE

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹546.50
Price